[Cigarette smoking--threat from first days of life]

Ewa Gajewska1, Roksana Malak, Ewa Mojs

  • 1Katedra i Klinika Fizjoterapii, Reumatologii i Rehabilitacji, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu. karasinska1@wp.pl

Przeglad Lekarski
|February 5, 2009
PubMed

Insights

Smoking during pregnancy harms newborns, causing numerous health issues. Exposure to environmental tobacco smoke (ETS) carries similar risks, highlighting the need for prenatal smoking cessation.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Public Health

Context:

  • Maternal smoking and exposure to environmental tobacco smoke (ETS) during pregnancy pose significant risks to fetal development.
  • Prenatal exposure to toxic tobacco components can lead to a wide range of adverse outcomes for newborns.
  • The consequences of smoking during pregnancy are severe and impact multiple organ systems.

Purpose:

  • To outline the detrimental effects of maternal smoking and ETS exposure on newborns.
  • To emphasize the correlation between prenatal smoke exposure and various infant health problems.
  • To underscore the importance of early-life prophylaxis against smoking-induced illnesses.

Summary:

  • Maternal smoking and exposure to environmental tobacco smoke (ETS) during pregnancy are linked to premature rupture of membranes, premature birth, and intrauterine growth retardation (IUGR).
  • Infants exposed to smoke in utero may experience low birth weight, reduced body length, impaired lung function (hypoxia), and delayed neurological and respiratory development.
  • Prenatal smoke exposure is also associated with an increased risk of sudden infant death syndrome (SIDS), obesity, allergies, hypertension, and tumors in children.

Impact:

  • Highlights the critical need for smoking cessation programs for pregnant individuals.
  • Informs healthcare providers about the extensive risks associated with prenatal smoke exposure.
  • Stresses the importance of preventative measures from the earliest stages of life to mitigate long-term health consequences.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...